z-logo
Premium
Fragile X syndrome therapy: to respond or not to respond may be a matter of methylation
Author(s) -
Pouladi MA
Publication year - 2011
Publication title -
clinical genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.543
H-Index - 102
eISSN - 1399-0004
pISSN - 0009-9163
DOI - 10.1111/j.1399-0004.2011.01663.x
Subject(s) - methylation , dna methylation , fragile x syndrome , genetics , medicine , biology , gene , gene expression
Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056 Jacquemont et al. (2011) Science Translational Medicine 3 (64):64ra1

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom